These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 12727021)
61. Fractalkine and its receptor, CX3CR1, upregulation in streptozotocin-induced diabetic kidneys. Kikuchi Y; Ikee R; Hemmi N; Hyodo N; Saigusa T; Namikoshi T; Yamada M; Suzuki S; Miura S Nephron Exp Nephrol; 2004; 97(1):e17-25. PubMed ID: 15153757 [TBL] [Abstract][Full Text] [Related]
62. Expression of lymphotoxin-alpha by keratinocytes: a further mediator for the lichenoid reaction. Middel P; Lippert U; Hummel KM; Bertsch HP; Artuc M; Schweyer S; Radzun HJ Pathobiology; 2000; 68(6):291-300. PubMed ID: 11493763 [TBL] [Abstract][Full Text] [Related]
63. Fractalkine expression and the recruitment of CX3CR1+ cells in the prolonged mesangial proliferative glomerulonephritis. Ito Y; Kawachi H; Morioka Y; Nakatsue T; Koike H; Ikezumi Y; Oyanagi A; Natori Y; Natori Y; Nakamura T; Gejyo F; Shimizu F Kidney Int; 2002 Jun; 61(6):2044-57. PubMed ID: 12028445 [TBL] [Abstract][Full Text] [Related]
64. [Expression of fractalkine and its receptor in acute cardiac allografts rejection]. Gu X; Tang XD; Gu SY; Yang SQ; Zhou PJ; Tan JM Zhonghua Wai Ke Za Zhi; 2003 Feb; 41(2):139-42. PubMed ID: 12783679 [TBL] [Abstract][Full Text] [Related]
65. Induction of fractalkine by endothelial cells under shear stress. Moatti D; Vele O; Nemerson Y Blood Coagul Fibrinolysis; 2004 Mar; 15(2):197. PubMed ID: 15091008 [No Abstract] [Full Text] [Related]
67. Aspirin inhibits tumor necrosis factor-alpha-stimulated fractalkine expression in human umbilical vein endothelial cells. Jiang DQ; Liu H; Zhang SB; Zhang XL Chin Med J (Engl); 2009 May; 122(10):1147-53. PubMed ID: 19493461 [TBL] [Abstract][Full Text] [Related]
68. Identification of fractalkine, a CX3C-type chemokine, as a direct target of p53. Shiraishi K; Fukuda S; Mori T; Matsuda K; Yamaguchi T; Tanikawa C; Ogawa M; Nakamura Y; Arakawa H Cancer Res; 2000 Jul; 60(14):3722-6. PubMed ID: 10919640 [TBL] [Abstract][Full Text] [Related]
69. Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Ruth JH; Volin MV; Haines GK; Woodruff DC; Katschke KJ; Woods JM; Park CC; Morel JC; Koch AE Arthritis Rheum; 2001 Jul; 44(7):1568-81. PubMed ID: 11465708 [TBL] [Abstract][Full Text] [Related]
70. Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer. Vitale S; Cambien B; Karimdjee BF; Barthel R; Staccini P; Luci C; Breittmayer V; Anjuère F; Schmid-Alliana A; Schmid-Antomarchi H Gut; 2007 Mar; 56(3):365-72. PubMed ID: 16870716 [TBL] [Abstract][Full Text] [Related]
71. The CX3C chemokine fractalkine induces vascular dysfunction by generation of superoxide anions. Schäfer A; Schulz C; Fraccarollo D; Tas P; Leutke M; Eigenthaler M; Seidl S; Heider P; Ertl G; Massberg S; Bauersachs J Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):55-62. PubMed ID: 17082482 [TBL] [Abstract][Full Text] [Related]
72. Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells. Guo J; Zhang M; Wang B; Yuan Z; Guo Z; Chen T; Yu Y; Qin Z; Cao X Int J Cancer; 2003 Jan; 103(2):212-20. PubMed ID: 12455035 [TBL] [Abstract][Full Text] [Related]
73. Inflammatory agents regulate in vivo expression of fractalkine in endothelial cells of the rat heart. Harrison JK; Jiang Y; Wees EA; Salafranca MN; Liang HX; Feng L; Belardinelli L J Leukoc Biol; 1999 Dec; 66(6):937-44. PubMed ID: 10614775 [TBL] [Abstract][Full Text] [Related]
74. Activation of human natural killer cells by recombinant membrane-expressed fractalkine on the surface of tumor cells. Zhang X; Wei H; Chen Q; Tian Z Oncol Rep; 2007 Jun; 17(6):1371-5. PubMed ID: 17487393 [TBL] [Abstract][Full Text] [Related]
75. Recombinant human activated protein C upregulates the release of soluble fractalkine from human endothelial cells. Brueckmann M; Nahrup AS; Lang S; Bertsch T; Fukudome K; Liebe V; Kaden JJ; Hoffmann U; Borggrefe M; Huhle G Br J Haematol; 2006 Jun; 133(5):550-7. PubMed ID: 16681644 [TBL] [Abstract][Full Text] [Related]
76. Functional expression of the fractalkine (CX3C) receptor and its regulation by lipopolysaccharide in rat microglia. Boddeke EW; Meigel I; Frentzel S; Biber K; Renn LQ; Gebicke-Härter P Eur J Pharmacol; 1999 Jun; 374(2):309-13. PubMed ID: 10422773 [TBL] [Abstract][Full Text] [Related]
78. Characterization of synergistic induction of CX3CL1/fractalkine by TNF-alpha and IFN-gamma in vascular endothelial cells: an essential role for TNF-alpha in post-transcriptional regulation of CX3CL1. Matsumiya T; Ota K; Imaizumi T; Yoshida H; Kimura H; Satoh K J Immunol; 2010 Apr; 184(8):4205-14. PubMed ID: 20231691 [TBL] [Abstract][Full Text] [Related]
79. Inhibition of cytokine-induced fractalkine production by bacterial invasion of human-dermal fibroblasts. Fahy OL; Coates NJ; McColl SR Lab Invest; 2003 May; 83(5):721-30. PubMed ID: 12746481 [TBL] [Abstract][Full Text] [Related]
80. RANTES expression in psoriatic skin, and regulation of RANTES and IL-8 production in cultured epidermal keratinocytes by active vitamin D3 (tacalcitol). Fukuoka M; Ogino Y; Sato H; Ohta T; Komoriya K; Nishioka K; Katayama I Br J Dermatol; 1998 Jan; 138(1):63-70. PubMed ID: 9536224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]